ACAD: ACADIA Pharmaceuticals Inc

25.99 USD 0.24 (0.91%)

Sector: Healthcare Base: US Dollar Profit currency: US Dollar

ACAD exchange rate has changed by -0.91% for today. During the day, the instrument was traded at a low of 25.82 and at a high of 26.30.

Follow ACADIA Pharmaceuticals Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.

Full Screen Chart

ACAD News

16:27 Axsome Shares Up 20% in a Month: How Should You Play the Stock?
20:12 Acadia Pharmaceuticals appoints Katcheves as chief business officer
14:38 Acadia Pharmaceuticals stock hits 52-week high at $25.90
13:49 JAZZ Inks $1B Licensing Deal With Saniona for Epilepsy Drug
20:52 Mizuho lowers Acadia Pharmaceuticals stock price target to $22 from $32
13:56 Acadia Pharmaceuticals stock hits 52-week high at 25.24 USD
14:41 Acadia Pharmaceuticals stock price target raised to $24 from $18 at Stifel
14:04 Acadia Q2 Earnings Beat, Nuplazid & Daybue Sales Drive Revenue Growth
12:02 Mizuho raises Acadia Pharmaceuticals stock price target on solid earnings
08:57 Acadia Pharmaceuticals stock price target raised to $38 from $37 at Citizens JMP
21:20 Acadia Pharmaceuticals Q2 2025 slides: revenue up 9%, raises full-year guidance
21:15 Acadia Pharmaceuticals (ACAD) Tops Q2 Earnings and Revenue Estimates
22:00 Adaptive Biotechnologies (ADPT) Reports Q2 Loss, Beats Revenue Estimates
13:32 Catalyst Pharmaceutics to Report Q2 Earnings: What's in the Cards?
16:23 Recursion Pharmaceuticals to Report Q2 Earnings: What's in the Cards?
15:07 Sarepta to Report Q2 Earnings: What's in Store for the Stock?
15:40 GMAB vs. ACAD: Which Stock Is the Better Value Option?
14:00 Acadia Pharmaceuticals (ACAD) Expected to Beat Earnings Estimates: Should You Buy?
08:32 ACADIA Pharmaceutical: ACP-101 Read-Out Is Not Fully Priced In (NASDAQ:ACAD)
12:00 Acadia Emerges From Behind The Scenes With A Potential $12 Billion Opportunity
14:49 Acadia stock price target raised to $32 from $22 at UBS on growth outlook
11:36 Acadia Pharmaceuticals stock rating reiterated by H.C. Wainwright
13:21 Acadia stock maintains outperform rating at RBC on pipeline potential
12:55 Acadia Pharmaceuticals stock maintains outperform rating at BMO Capital

Daily Range

25.82 26.30

Year Range

13.40 26.64

Previous Close: 26.23
Open: 26.19

Bid: 25.99
Ask: 26.29

Low: 25.82
High: 26.30

Volume: 2.026 K

Daily Change: -0.91%
Month Change: 9.66%

6 Months Change: 32.00%
Year Change: 57.04%

30 August, Saturday